Akcea Therapeutics and Ambry Genetics are partnering to offer no-cost, confidential genetic testing and confidential genetic counseling to patients suspected of having or clinically diagnosed with hATTR amyloidosis through the hATTR Compass program.
hATTR Compass is designed to:
- Help accelerate or confirm the diagnosis of hATTR amyloidosis
- Provide support and resources to patients, caregivers and healthcare professionals throughout the genetic testing process
- Empower patients and their healthcare professionals to make the most informed decisions about their health care
Considering genetic testing for hATTR amyloidosis?
hATTR Compass Patient and Caregiver Resource Guide
hATTR Compass Healthcare Professional Resource Guide